BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19727403)

  • 21. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
    Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
    Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells.
    Ando A; Hashimoto N; Sakamoto K; Omote N; Miyazaki S; Nakahara Y; Imaizumi K; Kawabe T; Hasegawa Y
    Cancer Sci; 2019 Jun; 110(6):1959-1973. PubMed ID: 31004547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
    Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells.
    Guan G; Zhang Y; Lu Y; Liu L; Shi D; Wen Y; Yang L; Ma Q; Liu T; Zhu X; Qiu X; Zhou Y
    Cancer Lett; 2015 Feb; 357(1):254-264. PubMed ID: 25444927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess TGF-β mediates muscle weakness associated with bone metastases in mice.
    Waning DL; Mohammad KS; Reiken S; Xie W; Andersson DC; John S; Chiechi A; Wright LE; Umanskaya A; Niewolna M; Trivedi T; Charkhzarrin S; Khatiwada P; Wronska A; Haynes A; Benassi MS; Witzmann FA; Zhen G; Wang X; Cao X; Roodman GD; Marks AR; Guise TA
    Nat Med; 2015 Nov; 21(11):1262-1271. PubMed ID: 26457758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
    Mimeault M; Batra SK
    J Cell Mol Med; 2013 Jan; 17(1):30-54. PubMed ID: 23301832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer.
    Shao S; Zhao L; An G; Zhang L; Jing X; Luo M; Li W; Meng D; Ning Q; Zhao X; Lei J
    FASEB J; 2020 Aug; 34(8):10860-10870. PubMed ID: 32592239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
    Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
    J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microenvironment Stimuli HGF and Hypoxia Differently Affected miR-125b and Ets-1 Function with Opposite Effects on the Invasiveness of Bone Metastatic Cells: A Comparison with Breast Carcinoma Cells.
    Matteucci E; Maroni P; Nicassio F; Ghini F; Bendinelli P; Desiderio MA
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
    Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance and in vitro cellular regulation of hypoxia mimicry on HIF-1α and downstream genes in canine appendicular osteosarcoma.
    Gola C; Iussich S; Noury S; Martano M; Gattino F; Morello E; Martignani E; Maniscalco L; Accornero P; Buracco P; Aresu L; De Maria R
    Vet J; 2020 Oct; 264():105538. PubMed ID: 33012439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
    Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
    BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.
    Javelaud D; Mohammad KS; McKenna CR; Fournier P; Luciani F; Niewolna M; André J; Delmas V; Larue L; Guise TA; Mauviel A
    Cancer Res; 2007 Mar; 67(5):2317-24. PubMed ID: 17332363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
    Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
    Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of HIF-1
    Schoos A; Gabriel C; Knab VM; Fux DA
    J Pharmacol Exp Ther; 2019 Sep; 370(3):480-489. PubMed ID: 31300611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
    Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
    J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.